Clinical Trial Update: Feasibility of Early Gabapentin as an Intervention for Neurorecovery [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating the feasibility of early gabapentin to support neurorecovery after spinal cord injury is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: MetroHealth Medical Center | Conditions: Spinal Cord Injuries | Phase 4 | Status: RECRUITING